The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Epilepsy Management in Pregnancy

Balanced antiepileptic therapy and monitoring to prevent seizures while minimizing teratogenic risk

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Kadın Hastalıkları ve Doğum department. Book Appointment →

What is Epilepsy Management in Pregnancy?

Epilepsy affects approximately 0.5-1 percent of pregnant women.

Pregnancy alters AED pharmacokinetics: increased clearance, decreased protein binding, altered absorption.

Approximately one-third of women with epilepsy experience increased seizure frequency during pregnancy.

AEDs carry varying teratogenic risk: valproate highest (10-11 percent major malformations); lamotrigine, levetiracetam lower (2-3 percent).

Folic acid supplementation 4-5 mg daily preconception and first trimester recommended.

Neonatal vitamin K prophylaxis essential due to enzyme-inducing AEDs.

Symptoms

Generalized tonic-clonic seizure: loss of consciousness, motor activity, post-ictal confusion.
Focal seizures: sensory, motor, autonomic, or psychic symptoms.
Increased seizure frequency, breakthrough seizures despite usual medications.
Status epilepticus - medical emergency.
Maternal injury from seizures: trauma, aspiration, placental abruption.
Fetal injury risk from generalized seizures: hypoxia, growth restriction, miscarriage.

Risk Factors

Sleep deprivation, stress, missed medications, hyperventilation.
Drug-resistant epilepsy.
AED non-compliance due to nausea, fear of teratogenicity, or vomiting.
Genetic epilepsy syndromes with higher seizure burden.
Polytherapy versus monotherapy (higher teratogenic risk with polytherapy).
Valproate exposure - particularly high risk for neural tube defects, cognitive impairment.

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Preconception counseling for all women with epilepsy of childbearing age.
  • Pregnancy planning - optimize AED regimen and start folic acid 3 months before conception.
  • First-trimester seizure increase or new seizure types.
  • Status epilepticus or cluster seizures - immediate emergency care.
  • Severe morning sickness affecting AED absorption.
  • Postpartum: medication reassessment, sleep deprivation management, breastfeeding consultation.

Treatment Methods

01
Preconception planning: switch from valproate when possible; lamotrigine, levetiracetam preferred.
02
Use lowest effective monotherapy dose; avoid polytherapy if feasible.
03
Folic acid 4-5 mg daily from 3 months preconception through first trimester (some recommend throughout pregnancy).
04
Therapeutic drug monitoring of AED levels each trimester (especially lamotrigine - significant clearance increase).
05
Detailed anatomy ultrasound and fetal echocardiography at 18-22 weeks.
06
Vitamin K 10 mg daily oral in last 4 weeks for women on enzyme-inducing AEDs (phenytoin, phenobarbital, carbamazepine); IM vitamin K to neonate at birth.
07
Postpartum: gradual AED dose reduction over 1-2 weeks if increased during pregnancy.
08
Breastfeeding generally encouraged - benefits outweigh small AED transfer; monitor infant for sedation.

Which Department to Visit?

You can visit our Kadın Hastalıkları ve Doğum department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Kadın Hastalıkları ve Doğum Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

Regular Gynecological Check-up

Kadın Hastalıkları ve Doğum

Regular gynecological check-ups enable early diagnosis of many women's diseases and increase treatment success. It is recommended that every sexually active woman or woman over 21 see a gynecologist at least once a year.

Cervical Cancer

Kadın Hastalıkları ve Doğum

Cervical cancer develops from uncontrolled growth of cells in the cervix and is among the most common women's cancers worldwide. Precancerous lesions can be recognized with regular Pap smear and HPV testing.

HPV and Vaccination

Kadın Hastalıkları ve Doğum

HPV is a common virus transmitted sexually that can lead to certain types of cancer. Vaccination provides over 90% protection against high-risk HPV strains.

Ovarian Cyst

Kadın Hastalıkları ve Doğum

Ovarian cysts are fluid-filled sacs that form in or on the ovarian tissue. Most are asymptomatic and disappear spontaneously; however, large or complex cysts can cause pain and complications.

Endometriosis

Kadın Hastalıkları ve Doğum

Endometriosis affects about 10% of women of reproductive age, causing cyclic pelvic pain, dysmenorrhea, dyspareunia, and infertility; combined medical and laparoscopic treatment improves quality of life.

Uterine Fibroids

Kadın Hastalıkları ve Doğum

Uterine fibroids are benign tumors developing from the uterine muscle layer. They affect 20-50% of women of reproductive age; most are asymptomatic, but can cause bleeding and pain.

Polycystic Ovary Syndrome (PCOS)

Kadın Hastalıkları ve Doğum

PCOS is the most common endocrine disease affecting approximately 10% of women of reproductive age, characterized by androgen excess, ovulation disorder, and polycystic ovarian appearance.

Menopause

Kadın Hastalıkları ve Doğum

Menopause is the life stage defined by not having a period for 12 consecutive months and the natural cessation of ovarian function. The average age is 51, but it can vary between 45-55 years.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.